Solid multi-year partnership. This tender is shared with Abbott who have their HIV test still pending, and this one million test order is just the baseline to expand from.
"To date, Unitaid investment has resulted in 5 million kits being distributed, with 21 million kits set to be procured by countries between 2020 and 2023."
Atomo is in the box seat to capture a significant portion of this market, even at $2-3 USD per test this is significant annuity style revenue.
It is another pillar in Atomo's global plan with a global blue chip partner in Viatris ($16B USD Market Cap), who recently mentioned Atomo in their investor day presentation.
Solid multi-year partnership. This tender is shared with Abbott...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $4.355K | 222.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1968855 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 416397 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |